Medications
Endocrine and Metabolism
Endocrine and Metabolism
Androgens
| Fluoxymesterone | |
| Methyltestosterone | ANDROID |
| Nandrolone | DECA-DURABOLIN |
| Oxandrolone | OXANDRIN |
| Testosterone | |
A – approved while on duty; review pre-and post-treatment testosterone levels for appropriate therapy*; monitor for behavior changes; off-label uses should be carefully evaluated
*Bhasim S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006;91(6):1995-2010. Available at: http://press.endocrine.org/doi/pdf/10.1210/jc.2009-2354. Accessed March 14, 2016.
Contraceptives – Oral
| Ethinylestradiol and desogestrel | CYCLESSA |
| Ethinylestradiol anddrospirenone | YASMIN |
| Ethinylestradiol and ethynodiol | DEMULEN |
| Ethinylestradiol and levonorgestrel | ALESSE |
| Ethinylestradiol and norethindrone | LOESTRIN |
| Ethinylestradiol and norgestimate | ORTHO-CYCLEN, ORTHO TRI-CYCLEN |
| Ethinylestradiol and norgestrel | OVRAL |
| Levonorgestrel | PLAN B |
| Mestranol and norethindrone | ORTHO-NOVUM |
| Norethindrone | MICRONOR |
| Norgestrel | OVRETTE |
A – approved while on duty
Contraceptives – Other
| Ethinylestradiol and etonorgestre | INUVARING |
| Ethinylestradiol and norelgestromin | ORTHO EVRA |
| Etonogestrel | IMPLANON |
| Medroxiprogesterone injectable | DEPO-PROVERA |
A – approved while on duty
Corticosteroids
| Betamethasone | CELESTONE |
| Cortisone | CORTONE |
| Dexamethasone | DECADRON |
| Fludrocortisone | FLORINEF |
| Hydrocortisone | CORTEF |
| Methylprednisolone | MEDOL |
| Prednisolone | ORAPRED, PRELONE |
| Prednisone | STERAPRED |
| Triamcinolone | ARISTOCORT, KENALOG |
A – approved while on duty; monitor for behavior changes
Diabetes Glycemic Control Agents – Oral
| Acarbose | PRECOSE |
| Exenatide | BYETTA |
| Glimepiride | AMARYL |
| Glipizide | GLUCOTROL |
| Glyburide | DIABETA, MICRONASE |
| Metformin | GLUCOPHAGE |
| Miglitol | GLYSET |
| Nateglinide | STARLIX |
| Pioglitazone | PRANDIN |
| Rosiglitazone | AVANDIA |
| Tolazamide | TOLINASE |
| Tolbutamide | ORINASE |
T – temporary restriction at the beginning of treatment
D – diagnosis may dictate restriction (see Chapter 4.3 on diabetes)
Estrogens
| Conjugated estrogens | PREMARIN |
| Conjugated synthetic estrogens | CENESTIN, ENJUVIA |
| Esterified estrogens | MENEST |
| Estradiol | ESTRACE, ESTRING, VAGIFEM |
| Estradiol acetate | FEMTRACE, FEMRING |
| Estradiolcypionate | DEPO-ESTRADIOL |
| Estradiol topical and transdermal | CLIMARA, ESTROGEL |
| Estradiol valerate | DELESTROGEN |
| Estropipate | OGEN |
A – approved while on duty
Gonadotropin-releasing Hormone
| Cetrorelix acetate | CETROTIDE |
| Ganirelix | FOLLISTIM/ANTAGON |
| Goserelin | ZOLADEX |
| Leuprolide | LUPRON |
| Nafarelin | SYNAREL |
A – approved while on duty
Gout
| Allopurinol | ZYLOPRIM |
| Colchicine | COLCHICINE |
| Colchicine-Probenecid | COL-BENEMID |
| Probenecid | BENEMID |
A – approved while on duty
Hormone Replacement Combinations
| Conjugated estrogens and medroxyprogesterone | PREMPRO |
| Esterified estrogens and medroxyprogesterone | PREMPHASE |
| Esterified estrogens and methyltestosterone | ESTRATEST |
| Estradiol and norethindrone | ACTIVELLA |
| Estradiol and norgestimate | PREFEST |
| Estradiol and levonorgestrel | CLIMARA PRO |
| Ethinylestradiol and norethindrone | FEMHRT |
A – approved while on duty
Insulins
| Insulin inhaled | EXUBERA |
| Insulin injectable |
T – temporary restriction at beginning of treatment
D – diagnosis may dictate restriction (see Chapter 4.3 – Diabetes)
Osteoporosis Treatments
| Alendronate | FOSAMAX |
| Calcitonin-salmon | MIACALCIN |
| Ibandronate | BONIVA |
| Raloxigene | EVISTA |
| Risedronate | ACTONEL |
A – approved while on duty
Progestins
| Hydroxyprogesterone caproate | |
| Medroxyprogesterone injectable | DEPO-PROVERA |
| Medroxyprogesterone oral | PROVERA |
| Megestrol | MEGACE |
| Norethindrone | AYGESTIN |
| Progesterone | CRINONE, PROMETRIUM |
A – approved while on duty
Thyroid Disorder Medications
| Levothyroxine | SYNTHROID |
| Liothyronine | CYTOMEL |
| Methimazole | TAPAZOLE |
| Propylthiouracil | PTU |
| Thyroid desiccated | ARMOURTHYROID |
A – approved while on duty; monitor for behavior changes, tachycardia, tremor, heat injury; monitor levels of the thyroid hormones
D – diagnosis may dictate restriction
Other Endocrine Disorder Agents
| Bromocriptine | PARLODEL |
T – temporary restriction at beginning of treatment; monitor for dizziness, sedation, orthostatic hypotension, behavior changes
| Cabergoline | DOSTINEX |
T – temporary restriction at beginning of treatment; monitor for dizziness, orthostatic hypotension
| Cinacalcet | SENSIPAR |
A – approved while on duty
D – diagnosis may dictate restriction
| Conivaptan | VAPRISOL |
D – diagnosis may dictate restriction
| Cosyntropin | CORTROSYN |
| Danazol | DANOCRINE |
A – approved while on duty
| Desmopressin Acetate | DDAVP |
T – temporary restriction at beginning of treatment; monitor for hyponatremia, hypertension, dizziness
D – diagnosis may dictate restriction
| Etidronate Disodium | DIDRONEL |
A – approved while on duty
| Exenatide | BYETTA |
T – temporary restriction at beginning of treatment
D – diagnosis may dictate restriction (see Chapter 4.3 – Diabetes)
| Glucagon | GLUCAGON |
LEO may take medication while on duty, but should seek medical attention immediately after taking medication
D – diagnosis may dictate restriction (see Chapter 4.3 on diabetes)
| Human growth hormone | ACCRETROPIN |
A – approved while on duty
| Lanthanum carbonate | FOSRENOL |
A – approved while on duty
D – diagnosis may dictate restriction
| Leuprolide | LUPRON |
| Levocarnitine | CARNITOR |
A – approved while on duty
| Mifepristone | MIFEPREX |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects)
| Pamidronate | AREDIA |
D – diagnosis may dictate restriction
| Pramlintide | SYMLIN |
T – temporary restriction at beginning of treatment
D – diagnosis may dictate restriction (see Chapter 4.3 – Diabetes)
| Raloxifene | EVISTA |
| Sevelamer | RENAGEL |
A – approved while on duty
| Sodium polystyrene sulfonate | KAYEXALATE |
A – approved while on duty
D – diagnosis may dictate restriction
| Tamoxifen | NOLVADEX |
| Teriparatide | FORTEO |
A – approved while on duty
| Vasopressin | PITRESSIN |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects)
| Zoledronic Acid | ZOMETA |
T – temporary restriction at beginning of treatment; monitor for dizziness, hypotension, behavior changes
D – diagnosis may dictate restriction